Sep 2026· Sheng wu gong cheng xue bao = Chinese journal of biotechnology· Vol 42 9, pp.
4018-4037
· 0 citations
Medicine
TL;DR
This study provides a robust strategy for developing efficient microbial cell factories for the production of glycosaminoglycans by developing an efficient genome-integrated Escherichia coli strain for chondroitin production based on the strain GZ17 previously constructed in the laboratory.
Vanillyl alcohol (VNA) is a high-value compound used in the pharmaceutical industry and other fields. Its microbial de novo biosynthesis is severely limited by the low catalytic efficiency of O-methyltransferase. Here, we constructed a V314I mutant of caffeate O-methyltransferase via structure-guided protein engineerin...
Jin-Yi Li, Yong Du, Jia Wang et al.· ACS Synthetic Biology· 0 citations
Angustmycin A (also known as guvermectin) is a rare N-nucleoside antibiotic with broad-spectrum antimicrobial activity and registered agricultural use as a plant growth-promoting biochemical pesticide. Native
Streptomyces
producers remain the primary production source, but their slow growth, long fermentation...
Hai-Bing He, Yu-Lan Qiu, Yue-Le Teng et al.· Microbial Cell Factories· 0 citations
A genomically integrated Mevalonate (MVA) pathway from Actinomycetota in E. coli BL21(DE3) is developed to enhance terpene precursor supply and provides potential reservoir of diverse chassis for the industrial production of terpenoid-derived compounds.
Wen-Chao Liu, Xueying Tian, Wai-Chuen Wong et al.· Metabolic Engineering· 0 citations
De novo biosynthesis of 4-vinylcatechol (VCAT), a valuable bio-based monomer and potent antioxidant, has emerged as a crucial objective due to its profound industrial and pharmacological significance. However, its biosynthesis is frequently hindered by limited precursor availability. In this study, we developed a highl...
E. Kaynak, Merve Seven, Hüseyin Balcı et al.· Biotechnology and Bioenginee...· 0 citations
A validated CRISPR-Cas9 strategy for high extracellular β-galactosidase secretion in the clinically established S. boulardii CNCM I-745 is demonstrated, providing a foundation for future studies where the potential of the developed strains is evaluated in clinically relevant settings.
J. Carvalho, David Sáez Moreno, Carlos E. Costa et al.· Microbiology Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.